Synta Pharma (SNTA) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts SNTA Hot Sheet
Price: $0.34 --0%
Financial Fact:
Research and development: 7.8M
Today's EPS Names:
CCEL, MHGU, PLG, More
Financial Fact:
Research and development: 7.8M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Synta Pharma (NASDAQ: SNTA) reported Q2 EPS of ($0.15), $0.03 better than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Synta Pharma (SNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Macquarie cuts Macau gaming sector forecasts on weak GGR growth
- Jefferies Upgrades Friedrich Vorwerk Group SE (VH2:GR) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
